체외막 산소공급장치 시장 : 양식, 연령, 구성요소, 용도, 최종사용자별 - 세계 예측(2025-2030년)

The Extracorporeal Membrane Oxygenation Machine Market was valued at USD 794.86 million in 2023, expected to reach USD 832.14 million in 2024, and is projected to grow at a CAGR of 4.55%, to USD 1,085.63 million by 2030.

Extracorporeal Membrane Oxygenation (ECMO) machines serve as critical life-support systems that provide advanced respiratory and cardiac support to patients whose heart and lungs are unable to function sufficiently on their own. These machines play a vital role in healthcare, particularly in critical care settings for patients with severe heart or lung failure. ECMO's primary applications include use in patients recovering from cardiac surgery, handling severe cases of respiratory distress, and assisting neonates with respiratory challenges. The necessity of ECMO machines is underscored by their ability to bridge patients to recovery or other forms of advanced therapy. The end-use scope predominantly covers hospitals, specialized respiratory and cardiac care centers, and advanced neonatal care units, where timely intervention can be life-saving. Key growth factors impacting the ECMO market include technological advancements that improve machine efficiency and safety, as well as the increasing prevalence of respiratory and cardiac conditions due to lifestyle changes and an aging population. The latest potential opportunities lie in the integration of artificial intelligence to optimize ECMO settings and enhance patient monitoring, along with expansion in emerging markets with growing healthcare infrastructure. However, challenges such as high costs, the need for specialized training, and potential complications arising from use, including bleeding and infection, limit broader adoption. To spur innovation and business growth, focus areas should include developing cost-effective ECMO solutions, enhancing user-friendliness to expand trained personnel, and targeting untapped regions. Research efforts could concentrate on materials minimizing adverse effects and systems that reduce the complexity of use. The market is characterized by high entry barriers due to technological, regulatory, and training demands, yet it presents lucrative growth for firms that successfully mitigate these challenges through innovative solutions and strategic partnerships.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Extracorporeal Membrane Oxygenation Machine Market

The Extracorporeal Membrane Oxygenation Machine Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Prevalence of cardiovascular and respiratory diseases
  • Adoption of ECMO for neonatal care and expansion of ECMO centers
• Market Restraints
  • Adverse recalls of ECMO machines
• Market Opportunities
  • Ongoing advancements in ECMO machines
  • Improving reimbursement scenario for ECMO machines worldwide
• Market Challenges
  • Potential complexity associated with the operation and maintenance of ECMO

Porter's Five Forces: A Strategic Tool for Navigating the Extracorporeal Membrane Oxygenation Machine Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Extracorporeal Membrane Oxygenation Machine Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Extracorporeal Membrane Oxygenation Machine Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Extracorporeal Membrane Oxygenation Machine Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Extracorporeal Membrane Oxygenation Machine Market

A detailed market share analysis in the Extracorporeal Membrane Oxygenation Machine Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Extracorporeal Membrane Oxygenation Machine Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Extracorporeal Membrane Oxygenation Machine Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Key Company Profiles

The report delves into recent significant developments in the Extracorporeal Membrane Oxygenation Machine Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Abiomed, Inc., Baxter International Inc., Braile Biomedica, Chalice Medical Ltd., CytoSorbents Corporation, Dragerwerk AG & Co. KGaA, Eurosets S.R.L., Getinge AB, Guangdong Pigeon Medical Apparatus Co.,Ltd., Hengko Technology Co., Ltd., Inspira Technologies OXY B.H.N. Ltd., LivaNova PLC, MC3 Cardiopulmonary, Medtronic PLC, MicroPort Scientific Corporation, Nipro Corporation, Origen Biomedical, Inc., Owgels Group, Senko Medical Instrument Mfg. Co., Ltd., Shenzhen Mindray Biomedical Electronics Co. Ltd., Technimount System, Terumo Corporation, XENIOS AG by Fresenius Medical Care AG & Co. KGaA, and ZOLL Medical Corporation by Asahi Kasei Corporation.

Market Segmentation & Coverage

This research report categorizes the Extracorporeal Membrane Oxygenation Machine Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Modality, market is studied across Arteriovenous ECMO, Venoarterial ECMO, and Venovenous ECMO.
• Based on Age, market is studied across Adult, Neonate, and Pediatric.
• Based on Component, market is studied across Anticoagulation Systems, Blender, Cannulae, Heat Exchanger, Monitoring Systems, Oxygenator, and Pump.
• Based on Application, market is studied across Cardiac Application, Extracorporeal Cardiopulmonary Resuscitation, and Respiratory Application.
• Based on End-User, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Prevalence of cardiovascular and respiratory diseases
    • 5.1.1.2. Adoption of ECMO for neonatal care and expansion of ECMO centers
  • 5.1.2. Restraints
    • 5.1.2.1. Adverse recalls of ECMO machines
  • 5.1.3. Opportunities
    • 5.1.3.1. Ongoing advancements in ECMO machines
    • 5.1.3.2. Improving reimbursement scenario for ECMO machines worldwide
  • 5.1.4. Challenges
    • 5.1.4.1. Potential complexity associated with the operation and maintenance of ECMO
• 5.2. Market Segmentation Analysis
  • 5.2.1. Modality: Rising utilization of venoarterial ECMO as it provides both cardiac and respiratory support
  • 5.2.2. Age: Increasing need for ECMO machines in adults owing to respiratory & cardiac disorders
  • 5.2.3. Component: Increasing need for durable and biocompatible oxygenators for ECMO machines
  • 5.2.4. Application: Proliferating usage of Extracorporeal Cardiopulmonary Resuscitation (ECPR) as it quickly restores oxygenated blood flow to vital organs
  • 5.2.5. End-User: Development of advanced ECMO machines to cater to dedicated intensive care units in hospitals
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Extracorporeal Membrane Oxygenation Machine Market, by Modality

• 6.1. Introduction
• 6.2. Arteriovenous ECMO
• 6.3. Venoarterial ECMO
• 6.4. Venovenous ECMO

7. Extracorporeal Membrane Oxygenation Machine Market, by Age

• 7.1. Introduction
• 7.2. Adult
• 7.3. Neonate
• 7.4. Pediatric

8. Extracorporeal Membrane Oxygenation Machine Market, by Component

• 8.1. Introduction
• 8.2. Anticoagulation Systems
• 8.3. Blender
• 8.4. Cannulae
• 8.5. Heat Exchanger
• 8.6. Monitoring Systems
• 8.7. Oxygenator
• 8.8. Pump

9. Extracorporeal Membrane Oxygenation Machine Market, by Application

• 9.1. Introduction
• 9.2. Cardiac Application
• 9.3. Extracorporeal Cardiopulmonary Resuscitation
• 9.4. Respiratory Application

10. Extracorporeal Membrane Oxygenation Machine Market, by End-User

• 10.1. Introduction
• 10.2. Ambulatory Surgical Centers
• 10.3. Hospitals
• 10.4. Specialty Clinics

11. Americas Extracorporeal Membrane Oxygenation Machine Market

• 11.1. Introduction
• 11.2. Argentina
• 11.3. Brazil
• 11.4. Canada
• 11.5. Mexico
• 11.6. United States

12. Asia-Pacific Extracorporeal Membrane Oxygenation Machine Market

• 12.1. Introduction
• 12.2. Australia
• 12.3. China
• 12.4. India
• 12.5. Indonesia
• 12.6. Japan
• 12.7. Malaysia
• 12.8. Philippines
• 12.9. Singapore
• 12.10. South Korea
• 12.11. Taiwan
• 12.12. Thailand
• 12.13. Vietnam

13. Europe, Middle East & Africa Extracorporeal Membrane Oxygenation Machine Market

• 13.1. Introduction
• 13.2. Denmark
• 13.3. Egypt
• 13.4. Finland
• 13.5. France
• 13.6. Germany
• 13.7. Israel
• 13.8. Italy
• 13.9. Netherlands
• 13.10. Nigeria
• 13.11. Norway
• 13.12. Poland
• 13.13. Qatar
• 13.14. Russia
• 13.15. Saudi Arabia
• 13.16. South Africa
• 13.17. Spain
• 13.18. Sweden
• 13.19. Switzerland
• 13.20. Turkey
• 13.21. United Arab Emirates
• 13.22. United Kingdom

14. Competitive Landscape

• 14.1. Market Share Analysis, 2023
• 14.2. FPNV Positioning Matrix, 2023
• 14.3. Competitive Scenario Analysis
  • 14.3.1. The Government of New South Wales (NSW)'s New Innovative Clinical Trial with Mobile Cardiac Treatment
  • 14.3.2. Inspira Technologies Unveils the INSPIRA ART Line of Medical Devices at the World's Largest Extracorporeal Life Support Conference
  • 14.3.3. AIIMS-R Starts ECMO Treatment
  • 14.3.4. MGM Healthcare Inaugurates Advanced ECMO Care Facility for Children
  • 14.3.5. Abbott's Life Support System Receives New FDA Clearances to Help Doctors Treat More Critically Ill Patients
  • 14.3.6. First Domestic ECMO Machine to Play Vital Role
  • 14.3.7. China Grants Market Approval to Self-Developed ECMO Device for Severe COVID-19 Cases

Companies Mentioned

• 1. Abbott Laboratories
• 2. Abiomed, Inc.
• 3. Baxter International Inc.
• 4. Braile Biomedica
• 5. Chalice Medical Ltd.
• 6. CytoSorbents Corporation
• 7. Dragerwerk AG & Co. KGaA
• 8. Eurosets S.R.L.
• 9. Getinge AB
• 10. Guangdong Pigeon Medical Apparatus Co.,Ltd.
• 11. Hengko Technology Co., Ltd.
• 12. Inspira Technologies OXY B.H.N. Ltd.
• 13. LivaNova PLC
• 14. MC3 Cardiopulmonary
• 15. Medtronic PLC
• 16. MicroPort Scientific Corporation
• 17. Nipro Corporation
• 18. Origen Biomedical, Inc.
• 19. Owgels Group
• 20. Senko Medical Instrument Mfg. Co., Ltd.
• 21. Shenzhen Mindray Biomedical Electronics Co. Ltd.
• 22. Technimount System
• 23. Terumo Corporation
• 24. XENIOS AG by Fresenius Medical Care AG & Co. KGaA
• 25. ZOLL Medical Corporation by Asahi Kasei Corporation